TFR1 as a Biomarker of Pulmonary Fibrosis Development in COPD Patients
Yuan Wu,1 Yu Jiang,2 Bin Xiao,3 Lijun Xie,1 Nanjiang Zhou,1 Aoguo Zeng,1 Cuizhong Liu1 1Department of General Medicine, Hunan Provincial People’s Hospital and The First-Affiliated of Hospital of Hunan Normal University, Changsha, 410005, People’s Republic of China; 2Institute of Emergency Medicine,...
Saved in:
| Main Authors: | Wu Y, Jiang Y, Xiao B, Xie L, Zhou N, Zeng A, Liu C |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-08-01
|
| Series: | International Journal of COPD |
| Subjects: | |
| Online Access: | https://www.dovepress.com/tfr1-as-a-biomarker-of-pulmonary-fibrosis-development-in-copd-patients-peer-reviewed-fulltext-article-COPD |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perilipin 5 alleviates ferroptosis of cardiomyocytes by targeting USP10-p53-TfR proteasome-dependent degradation
by: Jianqiao Zhao, et al.
Published: (2025-07-01) -
Alteration in gut microbiota accompanied by increased intestinal permeability and Tfh/Tfr imbalance in patients with active SLE
by: Xiaodi Chu, et al.
Published: (2025-05-01) -
Tempo effects in period TFR: Inspecting the role of shape and scale variations in a cohort model
by: Stefano Mazzuco, et al.
Published: (2025-03-01) -
Electroacupuncture stimulation improves pulmonary fibrosis by modulating ferroptosis in rats: multiscale analysis of transcriptome and proteome
by: Yange Tian, et al.
Published: (2025-08-01) -
Biomarkers of pulmonary fibrosis in COVID-19 and postcovid syndrome
by: M. K. Kurbanaliev, et al.
Published: (2022-10-01)